scispace - formally typeset
J

Junjun Liu

Researcher at Huazhong University of Science and Technology

Publications -  155
Citations -  3731

Junjun Liu is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Chemistry & Polyketide. The author has an hindex of 30, co-authored 142 publications receiving 2914 citations. Previous affiliations of Junjun Liu include University of Michigan & University of Kentucky.

Papers
More filters
Journal ArticleDOI

The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.

TL;DR: It is shown that WFA binds to the intermediate filament (IF) protein, vimentin, by covalently modifying its cysteine residue, which is present in the highly conserved alpha-helical coiled coil 2B domain.
Journal ArticleDOI

Most Efficient Cocaine Hydrolase Designed by Virtual Screening of Transition States

TL;DR: The novel computational design approach has led to discovery of the most efficient cocaine hydrolase, i.e., a human BChE mutant with an approximately 2000-fold improved catalytic efficiency, promising for therapeutic treatment of cocaine overdose and addiction as an exogenous enzyme in human.
Journal ArticleDOI

Phomopsterones A and B, Two Functionalized Ergostane-Type Steroids from the Endophytic Fungus Phomopsis sp. TJ507A

TL;DR: Two new functionalized ergostane-type steroids, phomopsterones A (1) and B (2), were isolated from the plant-derived Phomopsis sp.
Journal ArticleDOI

Design, Preparation, and Characterization of High-Activity Mutants of Human Butyrylcholinesterase Specific for Detoxification of Cocaine

TL;DR: Two representative BChE mutants have been confirmed to be potent in actual protection of mice from acute toxicity of a lethal dose of cocaine (180 mg/kg) and future direction for further improving the efficacy of the enzyme in the cocaine overdose treatment is revealed.
Journal ArticleDOI

Bioactive Acylphloroglucinols with Adamantyl Skeleton from Hypericum Sampsonii

TL;DR: Hyperisampsins A and D showed potent anti-HIV activities with EC50 of 2.97 and 0.97 μM and selectivity index of 4.3.70 and 7.1.70, respectively.